Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
   
Ask the Experts About

Understanding Your LabsUnderstanding Your Labs
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


RPR
Jan 24, 2010

I have just had a reactive Syphilis test result of 1:128 , I have had 2 shots of Bicillin and due a further shot next week . I understand that I am in the secondary stage of syphilis. My question is , is the 3 shots of Bicillin effective against my high RPR reading - I have been told to return in 6 months for a further RPR . If I have a reading of 1:128 what are my chances of getting Neurosyphilis?

Response from Dr. Holodniy

Given what you describe, you are receiving the appropriate treatment, and yes, you should return in 6 months to repeat the RPR titer. It would be extremely unlikely not to see the titer fall. You don't give any indication that your doctors thought that neurosyphilis was a possibility currently, in which case the treatment and workup would be different.



Previous
VL test results question
Next
what does this really mean?

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement